1
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Rabinowits G, Gerçel-Taylor C, Day JM,
Taylor DD and Kloecker GH: Exosomal microRNA: A diagnostic marker
for lung cancer. Clin Lung Cancer. 10:42–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Callegari E, Gramantieri L, Domenicali M,
D'Abundo L, Sabbioni S and Negrini M: MicroRNAs in liver cancer: A
model for investigating pathogenesis and novel therapeutic
approaches. Cell Death Differ. 22:46–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang JB, Song W, Wang YY, Liu MG, Sun MM
and Liu H: Study on correlation between PKIB and pAkt expression in
breast cancer tissues. Eur Rev Med Pharmacol Sci. 21:1264–1269.
2017.PubMed/NCBI
|
9
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids
Res. 36:D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang D, Fan Z, Liu F and Zuo J: Hsa-miR-21
and Hsa-miR-29 in tissue as potential diagnostic and prognostic
biomarkers for gastric cancer. Cell Physiol Biochem. 37:1454–1462.
2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: miR-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Shinden Y, Iguchi T, Akiyoshi S, Ueo H,
Ueda M, Hirata H, Sakimura S, Uchi R, Takano Y, Eguchi H, et al:
miR-29b is an indicator of prognosis in breast cancer patients. Mol
Clin Oncol. 3:919–923. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Qi Y, Huang Y, Pang L, Gu W, Wang N, Hu J,
Cui X, Zhang J, Zhao J, Liu C, et al: Prognostic value of the
MicroRNA-29 family in multiple human cancers: A meta-analysis and
systematic review. Clin Exp Pharmacol Physiol. 44:441–454. 2017.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Kwon JJ, Quirin K, Aljoufi A, Nafiseh A
and Kota J: Restoration of MYC-repressed miR-29 in pancreatic
cancer cells leads to increased reactive oxygen species and
gemcitabine sensitization. Cancer Res. 77 Suppl 13:LB–327. 2017.
View Article : Google Scholar
|
16
|
Kinoshita T, Nohata N, Hanazawa T, Kikkawa
N, Yamamoto N, Yoshino H, Itesako T, Enokida H, Nakagawa M, Okamoto
Y, et al: Tumour-suppressive microRNA-29s inhibit cancer cell
migration and invasion by targeting laminin-integrin signalling in
head and neck squamous cell carcinoma. Br J Cancer. 109:2636–2645.
2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Nishikawa R, Goto Y, Kojima S, Enokida H,
Chiyomaru T, Kinoshita T, Sakamoto S, Fuse M, Nakagawa M, Naya Y,
et al: Tumor-suppressive microRNA-29s inhibit cancer cell migration
and invasion via targeting LAMC1 in prostate cancer. Int J Oncol.
45:401–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Zhu X, Li D, Yu F, Jia C, Xie J, Ma Y, Fan
S, Cai H, Luo Q, Lv Z, et al: miR-194 inhibits the proliferation,
invasion, migration, and enhances the chemosensitivity of non-small
cell lung cancer cells by targeting forkhead box A1 protein.
Oncotarget. 7:13139–13152. 2016.PubMed/NCBI
|
19
|
Nofech-Mozes R, Khella HWZ, Scorilas A,
Youssef L, Krylov SN, Lianidou E, Sidiropoulos KG, Gabril M, Evans
A and Yousef GM: MicroRNA-194 is a marker for good prognosis in
clear cell renal cell carcinoma. Cancer Med. 5:656–664. 2016.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Nakamura K, Sawada K, Yoshimura A,
Nakatsuka E, Kinose Y, Mabuchi S and Kimura T: MiR-194 modulates
paclitaxel resistance in ovarian cancer cells through the
regulation of MDM-2 expression. Cancer Res. 77 Suppl 13:34362017.
View Article : Google Scholar
|
21
|
Wang B, Shen ZL, Gao ZD, Zhao G, Wang CY,
Yang Y, Zhang JZ, Yan YC, Shen C, Jiang KW, et al: MiR-194,
commonly repressed in colorectal cancer, suppresses tumor growth by
regulating the MAP4K4/c-Jun/MDM2 signaling pathway. Cell Cycle.
14:1046–1058. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Guo B, Hui Q, Zhang Y, Chang P and Tao K:
miR-194 is a negative regulator of GEF-H1 pathway in melanoma.
Oncol Rep. 36:2412–2420. 2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Mizuno K, Seki N, Mataki H, Matsushita R,
Kamikawaji K, Kumamoto T, Takagi K, Goto Y, Nishikawa R, Kato M, et
al: Tumor-suppressive microRNA-29 family inhibits cancer cell
migration and invasion directly targeting LOXL2 in lung squamous
cell carcinoma. Int J Oncol. 48:450–460. 2016. View Article : Google Scholar : PubMed/NCBI
|
24
|
Nishikawa R, Chiyomaru T, Enokida H,
Inoguchi S, Ishihara T, Matsushita R, Goto Y, Fukumoto I, Nakagawa
M and Seki N: Tumour-suppressive microRNA-29s directly regulate
LOXL2 expression and inhibit cancer cell migration and invasion in
renal cell carcinoma. FEBS Lett. 589:2136–2145. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Liang T, Li L, Cheng Y, Ren C and Zhang G:
MicroRNA-194 promotes the growth, migration, and invasion of
ovarian carcinoma cells by targeting protein tyrosine phosphatase
nonreceptor type 12. Onco Targets Ther. 9:4307–4315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhang M, Zhuang Q and Cui L: MiR-194
inhibits cell proliferation and invasion via repression of RAP2B in
bladder cancer. Biomed Pharmacother. 80:268–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
27
|
Coffre M, Benhamou D, Riess D, Blumenberg
L, Snetkova V, Hines MJ, Chakraborty T, Bajwa S, Jensen K, Chong
MMW, et al: miRNAs are essential for the regulation of the
PI3K/AKT/FOXO pathway and receptor editing during B cell
maturation. Cell Rep. 17:2271–2285. 2016. View Article : Google Scholar : PubMed/NCBI
|
28
|
Masliah-Planchon J, Garinet S and Pasmant
E: RAS-MAPK pathway epigenetic activation in cancer: miRNAs in
action. Oncotarget. 7:38892–38907. 2016. View Article : Google Scholar : PubMed/NCBI
|
29
|
Madhavan B, Yue S, Galli U, Rana S, Gross
W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, et al:
Combined evaluation of a panel of protein and miRNA serum-exosome
biomarkers for pancreatic cancer diagnosis increases sensitivity
and specificity. Int J Cancer. 136:2616–2627. 2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Jiang X, Du L, Wang L, Li J, Liu Y, Zheng
G, Qu A, Zhang X, Pan H, Yang Y, et al: Serum microRNA expression
signatures identified from genome-wide microRNA profiling serve as
novel noninvasive biomarkers for diagnosis and recurrence of
bladder cancer. Int J Cancer. 136:854–862. 2015. View Article : Google Scholar : PubMed/NCBI
|